Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: A retrospective cohort study utilizing the Cubicin Outcomes Registry and Experience
Clinical Therapeutics, 10/29/09
Sakoulas G et al. – In this retrospective study, after controlling for clinical factors that are associated with suboptimal outcomes, clinical outcomes with daptomycin did not differ whether it was used as first–line therapy or after other antibiotics. Endocarditis, bacteremia, severe renal dysfunction, and DM were associated with higher rates of clinical failure of daptomycin treatment.
Related Articles
Efficacy of High Doses of Daptomycin versus Alternative Therapies against Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureus
Antimicrobial Agents and Chemotherapy, 10/06/09
Relevance Score: 66%
Aryl Rhodanines Specifically Inhibit Staphylococcal and Enterococcal Biofilm Formation
Antimicrobial Agents and Chemotherapy, 10/09/09
Relevance Score: 65%
Management of the Catheter in Documented Catheter-Related Coagulase-Negative Staphylococcal Bacteremia: Remove or Retain
Clinical Infectious Diseases, 10/07/09
Relevance Score: 65%
Telavancin: A Novel Lipoglycopeptide
Clinical Infectious Diseases, 11/16/09
Relevance Score: 62%
The treatment of diabetic foot infections: focus on ertapenem
Vascular Health and Risk Management, 11/09/09
Relevance Score: 48%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome
Diabetes Care, 11/25/09
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/25/09
Chronic Obstructive Pulmonary Disease: Role of Bacteria and Updated Guide to Antibacterial Selection in the Older Patient
Drugs & Aging, 11/25/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


